Health 360: Medical tourism dip, social media reels harming brain health and more смотреть онлайн

Описание видео

India's obesity drug market is entering a new phase as Novo Nordisk's key semaglutide patent expires, allowing Indian pharmaceutical companies to launch lower-cost versions of the active ingredient used in Ozempic and Wegovy. Рекомендуем Health 360: Medical tourism dip, social media reels harming brain health and more посмотреть онлайн видео бесплатно и без регистрации!